EE05272B1 - Merkaptoatsetlamiidi derivaadid, nende valmistamismeetod ja kasutamine - Google Patents

Merkaptoatsetlamiidi derivaadid, nende valmistamismeetod ja kasutamine

Info

Publication number: EE05272B1
Authority: EE; Estonia
Prior art keywords: compounds; derivatives; mercaptoacetamide; preparation; disclosed
Prior art date: 2001-04-12

Application number

EEP200300500A

Other languages

English (en)

Estonian (et)

Inventor

A. Flynn Gary

Mehdi Shujaath

Roger Koehl Jack

Ann Anderson Barbara

Gerken Manfred

Jablonka Bernd

Kleemann Heinz-Werner

Linz Wolfgang

Seiz Werner

Seuring Bernhard

Original Assignee

Aventis Pharma Deutschland Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-12

Filing date

2002-04-03

Publication date

2010-02-15

2001-08-08 Priority claimed from GBGB0119305.1A external-priority patent/GB0119305D0/en

2002-04-03 Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh

2003-12-15 Publication of EE200300500A publication Critical patent/EE200300500A/xx

2010-02-15 Publication of EE05272B1 publication Critical patent/EE05272B1/xx

Links

GYXHHICIFZSKKZ-UHFFFAOYSA-N 2-sulfanylacetamide Chemical class NC(=O)CS GYXHHICIFZSKKZ-UHFFFAOYSA-N 0.000 title abstract 2
150000001875 compounds Chemical class 0.000 abstract 3
206010007559 Cardiac failure congestive Diseases 0.000 abstract 1
206010019280 Heart failures Diseases 0.000 abstract 1
206010020772 Hypertension Diseases 0.000 abstract 1
102000003729 Neprilysin Human genes 0.000 abstract 1
108090000028 Neprilysin Proteins 0.000 abstract 1
102000004270 Peptidyl-Dipeptidase A Human genes 0.000 abstract 1
108090000882 Peptidyl-Dipeptidase A Proteins 0.000 abstract 1
230000005764 inhibitory process Effects 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Cardiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Cephalosporin Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

EEP200300500A 2001-04-12 2002-04-03 Merkaptoatsetlamiidi derivaadid, nende valmistamismeetod ja kasutamine EE05272B1 (et)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US28330501P	2001-04-12	2001-04-12
GBGB0119305.1A GB0119305D0 (en)	2001-04-12	2001-08-08	Mercaptoacetylamide derivatives,a process for their preparation and their use
PCT/EP2002/003668 WO2002083671A1 (fr)	2001-04-12	2002-04-03	Derives de mercaptoacetylamide, procede de preparation et utilisation de ces composes

Publications (2)

Publication Number	Publication Date
EE200300500A EE200300500A (et)	2003-12-15
EE05272B1 true EE05272B1 (et)	2010-02-15

Family

ID=26246410

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200300500A EE05272B1 (et)	2001-04-12	2002-04-03	Merkaptoatsetlamiidi derivaadid, nende valmistamismeetod ja kasutamine

Country Status (26)

Country	Link
EP (1)	EP1381605B1 (fr)
JP (1)	JP4392167B2 (fr)
CN (1)	CN1245404C (fr)
AT (1)	ATE286898T1 (fr)
AU (1)	AU2002304804B2 (fr)
BG (1)	BG66387B1 (fr)
BR (1)	BR0208889A (fr)
CA (1)	CA2443488C (fr)
CZ (1)	CZ299708B6 (fr)
DE (1)	DE60202602T2 (fr)
EE (1)	EE05272B1 (fr)
ES (1)	ES2232752T3 (fr)
HR (1)	HRP20030823B1 (fr)
HU (1)	HU229612B1 (fr)
IL (1)	IL158289A0 (fr)
MA (1)	MA26098A1 (fr)
MX (1)	MXPA03008613A (fr)
NO (1)	NO325655B1 (fr)
NZ (1)	NZ528825A (fr)
OA (1)	OA12502A (fr)
PL (1)	PL209338B1 (fr)
PT (1)	PT1381605E (fr)
RU (1)	RU2286346C2 (fr)
SI (1)	SI1381605T1 (fr)
SK (1)	SK287616B6 (fr)
WO (1)	WO2002083671A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10229180A1 (de) *	2002-06-28	2004-01-29	Aventis Pharma Deutschland Gmbh	Verwendung von Vasopeptidase-Inhibitoren bei der Behandlung von metabolischen Erkrankungen, Nephropathie und mit AGE assoziierten Erkrankungen
US8993631B2 (en)	2010-11-16	2015-03-31	Novartis Ag	Method of treating contrast-induced nephropathy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5430145A (en) *	1990-10-18	1995-07-04	Merrell Dow Pharmaceuticals Inc.	Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
CA2053340C (fr) *	1990-10-18	2002-04-02	Timothy P. Burkholder	Derives de mercaptoacetylamide utiles comme inhibiteurs de l'encephalinase et de l'ace
EP0534363B1 (fr) *	1991-09-27	1997-07-09	Merrell Pharmaceuticals Inc.	Dérivés d'indane-2-mercaptoacétylamide ayant une activité inhibitante d'enképhalinase et d'ACE
RU2127261C1 (ru) *	1993-06-11	1999-03-10	Эйсаи Ко., ЛТД	Производные аминокислоты
CA2140553A1 (fr) *	1993-06-11	1994-12-22	Hitoshi Oinuma	Derive d'un acide amine

2002
- 2002-04-03 AU AU2002304804A patent/AU2002304804B2/en not_active Ceased
- 2002-04-03 CA CA2443488A patent/CA2443488C/fr not_active Expired - Fee Related
- 2002-04-03 HR HR20030823A patent/HRP20030823B1/xx not_active IP Right Cessation
- 2002-04-03 PT PT02732549T patent/PT1381605E/pt unknown
- 2002-04-03 MX MXPA03008613A patent/MXPA03008613A/es active IP Right Grant
- 2002-04-03 EE EEP200300500A patent/EE05272B1/xx not_active IP Right Cessation
- 2002-04-03 BR BR0208889-4A patent/BR0208889A/pt not_active Application Discontinuation
- 2002-04-03 SI SI200230089T patent/SI1381605T1/xx unknown
- 2002-04-03 JP JP2002581426A patent/JP4392167B2/ja not_active Expired - Fee Related
- 2002-04-03 AT AT02732549T patent/ATE286898T1/de active
- 2002-04-03 ES ES02732549T patent/ES2232752T3/es not_active Expired - Lifetime
- 2002-04-03 IL IL15828902A patent/IL158289A0/xx unknown
- 2002-04-03 NZ NZ528825A patent/NZ528825A/en not_active IP Right Cessation
- 2002-04-03 PL PL363034A patent/PL209338B1/pl unknown
- 2002-04-03 DE DE60202602T patent/DE60202602T2/de not_active Expired - Lifetime
- 2002-04-03 HU HU0303482A patent/HU229612B1/hu not_active IP Right Cessation
- 2002-04-03 CZ CZ20032722A patent/CZ299708B6/cs not_active IP Right Cessation
- 2002-04-03 RU RU2003132875/04A patent/RU2286346C2/ru not_active IP Right Cessation
- 2002-04-03 OA OA1200300267A patent/OA12502A/fr unknown
- 2002-04-03 CN CNB028081005A patent/CN1245404C/zh not_active Expired - Fee Related
- 2002-04-03 EP EP02732549A patent/EP1381605B1/fr not_active Expired - Lifetime
- 2002-04-03 SK SK1255-2003A patent/SK287616B6/sk not_active IP Right Cessation
- 2002-04-03 WO PCT/EP2002/003668 patent/WO2002083671A1/fr not_active Ceased
2003
- 2003-09-16 MA MA27312A patent/MA26098A1/fr unknown
- 2003-09-26 BG BG108203A patent/BG66387B1/bg unknown
- 2003-10-02 NO NO20034412A patent/NO325655B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE60202602D1 (de)	2005-02-17
NO20034412L (no)	2003-10-02
CN1501926A (zh)	2004-06-02
OA12502A (fr)	2006-05-29
CN1245404C (zh)	2006-03-15
HU229612B1 (en)	2014-03-28
BG108203A (bg)	2004-12-30
AU2002304804B2 (en)	2007-05-10
EP1381605B1 (fr)	2005-01-12
SK12552003A3 (sk)	2004-03-02
PT1381605E (pt)	2005-03-31
RU2286346C2 (ru)	2006-10-27
BR0208889A (pt)	2004-06-29
SK287616B6 (sk)	2011-04-05
RU2003132875A (ru)	2005-03-20
SI1381605T1 (en)	2005-06-30
JP4392167B2 (ja)	2009-12-24
DE60202602T2 (de)	2006-03-23
EP1381605A1 (fr)	2004-01-21
CA2443488A1 (fr)	2002-10-24
CZ20032722A3 (cs)	2004-01-14
IL158289A0 (en)	2004-05-12
PL363034A1 (en)	2004-11-15
NO325655B1 (no)	2008-06-30
HK1061690A1 (en)	2004-09-30
EE200300500A (et)	2003-12-15
CA2443488C (fr)	2011-05-31
PL209338B1 (pl)	2011-08-31
NZ528825A (en)	2005-04-29
BG66387B1 (bg)	2013-11-29
MXPA03008613A (es)	2003-12-08
WO2002083671A1 (fr)	2002-10-24
MA26098A1 (fr)	2004-04-01
CZ299708B6 (cs)	2008-10-29
ATE286898T1 (de)	2005-01-15
HRP20030823A2 (en)	2005-08-31
HUP0303482A3 (en)	2012-12-28
ES2232752T3 (es)	2005-06-01
HUP0303482A2 (hu)	2004-01-28
HRP20030823B1 (en)	2011-10-31
NO20034412D0 (no)	2003-10-02
JP2004525966A (ja)	2004-08-26

Similar Documents

Publication	Publication Date	Title
TNSN03083A1 (en)	2005-12-23	Mercaptoacetylamide derivatives, a process for their preparation and their use
WO2003006425A3 (fr)	2003-11-27	Nouveaux composes convenant comme anti-inflammatoires, immuno-modulateurs et anti-proliferants
TR200100238T2 (tr)	2001-06-21	Yeni sübstitüe edilmiş pirazol türevleri
WO2002100845A8 (fr)	2003-03-20	Inhibiteurs de protease du hiv et compositions contenant ceux-ci, leurs applications pharmaceutiques, et matieres utiles a la synthese de ces inhibiteurs
MY134892A (en)	2007-12-31	Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
ATE309237T1 (de)	2005-11-15	Aromatische heterozyklische verbindungen als antientzündungwirkstoffe
WO2003082857A3 (fr)	2003-12-18	Polymorphes de lansoprazole et procedes de preparation de ces derniers
DK1456212T3 (da)	2007-04-02	6-aminomorphinanderivater, fremgangsmåder til fremstilling heraf og disses anvendelse
NO20065075L (no)	2006-11-16	Ikke-nukleosidbaserte revers-transkriptase-inhibitorer.
WO2004012663A3 (fr)	2004-07-08	Derives d'yhydantoine utilises comme inhibiteurs de metalloproteases maticielles et/ou d'enzyme de conversion de tnf-alpha
DE60015508T2 (de)	2005-04-21	C-16 ungesätigte fp-selektive prostaglandin analoge
SG165159A1 (en)	2010-10-28	Process for preparing 6-alkylidene penem derivatives
CY1109950T1 (el)	2014-09-10	Νεα παραγωγα 4,4-διθειοδις-(3-αμινοβουτανιο-1-σουλφονικων) και συνθεσεις που τα περιεχουν
NO20060417L (no)	2006-01-25	Fremgangsmate til fremstilling av 1-okten fra krakk-C4
AU2002357740A1 (en)	2003-06-23	Pyrazolo-pyridine derivatives as antiherpes agents
EE05272B1 (et)	2010-02-15	Merkaptoatsetlamiidi derivaadid, nende valmistamismeetod ja kasutamine
WO2003028645A3 (fr)	2004-03-25	Nouvelles compositions de carvedilol
EP1436279B8 (fr)	2008-10-29	Composes chimiques
DK1387841T3 (da)	2006-07-03	Hidtil ukendt azol- eller triazolderivater, fremgangsmåde til deres fremstilling og deres anvendelse som fungicider
MXPA03009723A (es)	2004-03-16	Procedimientos e intermediarios para preparar epoxidos substituidos de bencilo.
MXPA05003881A (es)	2005-10-05	Preparacion de compuestos triazospiro.
MXPA04001856A (es)	2004-06-15	Indan-1-oles c2-sustituidos y sus derivados, metodo para su produccion y su uso como medicamentos.
MXPA04001852A (es)	2004-06-15	Uso de sistemas indan-1-ol c2-sustituidas para la produccion de medicamentos para la profilaxis o tratamiento de obesidad.
WO2002083641A3 (fr)	2003-02-27	Amino-aza-cyclohexanes
MXPA04001846A (es)	2004-06-15	Indan-1-onas c2-substituidas y sus derivados, metodos para su produccion y su uso como medicamentos.

Legal Events

Date	Code	Title	Description
2011-02-15	KB4A	Valid patent at the end of a year	Effective date: 20101231
2016-12-15	MM4A	Lapsed by not paying the annual fees	Effective date: 20160403

EE05272B1 - Merkaptoatsetlamiidi derivaadid, nende valmistamismeetod ja kasutamine - Google Patents